Suppr超能文献

伪饥饿信号揭示氨基酸转运体 SLC7A11 是调节 Treg 细胞增殖潜力的关键决定因素。

Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential.

机构信息

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), 80131 Napoli, Italy; Unità di Neuroimmunologia, IRCCS Fondazione Santa Lucia, 00143 Roma, Italy.

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), 80131 Napoli, Italy.

出版信息

Immunity. 2021 Jul 13;54(7):1543-1560.e6. doi: 10.1016/j.immuni.2021.04.014. Epub 2021 May 17.

Abstract

Human CD4CD25FOXP3 regulatory T (Treg) cells are key players in the control of immunological self-tolerance and homeostasis. Here, we report that signals of pseudo-starvation reversed human Treg cell in vitro anergy through an integrated transcriptional response, pertaining to proliferation, metabolism, and transmembrane solute carrier transport. At the molecular level, the Treg cell proliferative response was dependent on the induction of the cystine/glutamate antiporter solute carrier (SLC)7A11, whose expression was controlled by the nuclear factor erythroid 2-related factor 2 (NRF2). SLC7A11 induction in Treg cells was impaired in subjects with relapsing-remitting multiple sclerosis (RRMS), an autoimmune disorder associated with reduced Treg cell proliferative capacity. Treatment of RRMS subjects with dimethyl fumarate (DMF) rescued SLC7A11 induction and fully recovered Treg cell expansion. These results suggest a previously unrecognized mechanism that may account for the progressive loss of Treg cells in autoimmunity and unveil SLC7A11 as major target for the rescue of Treg cell proliferation.

摘要

人类 CD4CD25FOXP3 调节性 T(Treg)细胞是控制免疫自身耐受和稳态的关键因素。在这里,我们报告称,伪饥饿信号通过涉及增殖、代谢和跨膜溶质载体转运的综合转录反应逆转了体外人类 Treg 细胞无能。在分子水平上,Treg 细胞的增殖反应依赖于胱氨酸/谷氨酸反向转运体溶质载体(SLC)7A11 的诱导,其表达受红细胞 2 相关因子 2(NRF2)的控制。在复发性缓解型多发性硬化症(RRMS)患者中,Treg 细胞中 SLC7A11 的诱导受损,这是一种与 Treg 细胞增殖能力降低相关的自身免疫性疾病。用二甲基富马酸(DMF)治疗 RRMS 患者可挽救 SLC7A11 的诱导,并完全恢复 Treg 细胞的扩增。这些结果表明了一种以前未知的机制,可能解释了自身免疫中 Treg 细胞的进行性丧失,并揭示 SLC7A11 是挽救 Treg 细胞增殖的主要靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验